The Global Adeno Associated Virus Vector Manufacturing Market size is witnessing significant growth driven by advancements in gene therapy research, increasing demand for gene-based treatments, and expanding applications in various industries. With a projected compound annual growth rate (CAGR) of approximately 12.8 %, the market is expected to reach USD 3.21 billion by 2030.